ROLE OF THE PHARMACIST IN MANAGING HIGH BLOOD PRESSURE OF HYPERTENSIVE PATIENTS IN PRIMARY CARE UNITS
Objective: The aim of this study was to evaluate the influence of pharmaceutical care on the control of high blood pressure (BP) in hypertensive patients.
Methods: The study included thirty hypertensive patients from primary or secondary healthcare located in the south of São Paulo, Brazil.
Results: The majority of patients was aged over 60 years (68.75%), non-smokers (90%), non-alcoholics (93.33%), did not practice physical activities (93.33%), and presented comorbidities and polypharmacy. The most common drug-related problems were drug-drug interactions, missed doses, incorrect frequency or time of administration, incorrect patient administration technique, and self-medication. The interventions used during the pharmaceutical consultations (PC) were based on the organization of medicines with tools such as a pillbox organizer (84.38%). A significant improvement in BP control (p<0.05) was observed when comparing BP measurements before and after the PC; however, the number of PCs did not influence the BP reduction.
Conclusion: Patient guidance and a simple intervention favor better patient understanding of medication administration schedules.
2. Strand LM, Guerrero RM, Nickman NA, Morley PC. Integrated patient-specific model of pharmacy practice. Am J Hosp Pharm 1990;47:550-4.
3. Ministério da Saude. Diário Oficial da União Brasil: Diário Oficial da União Brasil. Lei No. 8.080. Brazil: Ministério da Saude; 1990.
4. Araújo AL, de Freitas O. Conceptions of the pharmaceutical professional about the pharmaceutical assistance in basic health care units: Difficulties and elements for change. Rev Bras Cienc Farm 2006;42:134-46.
5. Fegadolli C, Cavaco AM, Fonseca DC. Revisiting concepts, attitudes and expectations of Brazilian pharmacists to the practice of pharmaceutical care: A qualitative perspective. Indian J Pharm Educ Res 2018;52:1-9.
6. Silva BB, Fegadolli C. Implementation of pharmaceutical care for older adults in the Brazilian public health system: A case study and realistic evaluation. BMC Health Serv Res 2020;20:37-51.
7. Que Institui Os Cuidados Farmacêuticos No Âmbito da Secretaria Municipal de Saúde do Município de São Paulo 1918/2016-SMS.G, Portaria No. 1.918/2016-SMS.G; 2016.
8. Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep 2018;20:12-20.
9. GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: A systematic analysis for the global burden of disease study 2015. Lancet 2016;388:1659-724.
10. World Health Organization. Noncommunicable Diseases Country Profiles 2018. Geneva: World Health Organization; 2018.
11. Plavnik FL, Machado CA, Malta D, Scala LC, Fuchs S. 7th Brazilian guideline of arterial hypertension. Braz J Hypertens 2017;24:12-6.
12. Ministério da Saúde. Relatório Anual de Gestão-2018; 2018. Available from: https://www.prefeitura.sp.gov.br/cidade/secretarias/upload/ saude/relatorio_anual_gestao_2018.pdf. 2018.
13. Ministério da Saúde. In: Ministério da Saúde SdVeS, Departamento de Vigilância de Doenças e Agravos Não Transmissíveis e Promoção da Saúde, editors. Health Brazil 2018: An Analysis of the Health Situation and of Chronic Diseases and Conditions: Challenges and Perspectives. Brasília: Ministério da Saúde; 2019. p. 414.
14. Mendes EV. Health care networks. Cien Saude Colet 2010;15:2297-305.
15. Menicucci TM. The unified national health system, 20 years: Assessment and perspectives. Cad Saude Publica 2009;25:1620-5.
16. Nascimento RC, Álvares J, Guerra AA Jr., Gomes IC, Silveira MR, Costa EA, et al. Polypharmacy: A challenge for the primary health care of the Brazilian unified health system. Rev Saude Publica 2017;51:19S.
17. Porter ME, Teisberg EO. Redefining Health Care: Creating Value- Based Competition on Results. Massachusetts, Boston: Harvard Business School Press; 2006.
18. Gossman W, Lew V, Ghassemzadeh S. SOAP notes. In: Stat Pearls. Treasure Island, FL: Stat Pearls Publishing; 2020.
19. Sando KR, Skoy E, Bradley C, Frenzel J, Kirwin J, Urteaga E. Assessment of SOAP note evaluation tools in colleges and schools of pharmacy. Curr Pharm Teach Learn 2017;9:576-84.
20. Guthold R, Stevens GA, Riley LM, Bull FC. Worldwide trends in insufficient physical activity from 2001 to 2016: A pooled analysis of 358 population-based surveys with 1.9 million participants. Lancet Glob Health 2018;6:e1077-86.
21. Malta DC, Silva M, Moura L, Morais OL. The implantation of the surveillance system for non-communicable diseases in Brazil, 2003 to 2015: Successes and challenges. Braz J Epidemiol 2017;20:661-75.
22. Malta DC, Bernal RT, Andrade S, Silva M, Velasquez-Melendez G. Prevalence of and factors associated with self-reported high blood pressure in Brazilian adults. Rev Saude Publica 2017;51:11S.
23. Morgado MP, Rolo SA, Pereira L, Castelo-Branco M. Blood pressure control and antihypertensive pharmacotherapy patterns in a hypertensive population of Eastern Central Region of Portugal. BMC Health Serv Res 2010;10:349.
24. Mengue SS, Bertoldi AD, Ramos LR, Farias MR, Oliveira MA, Tavares NU, et al. Access to and use of high blood pressure medications in Brazil. Rev Saude Publica 2016;50:8S.
25. Soler O, Barreto JO. Community-level pharmaceutical interventions to reduce the risks of polypharmacy in the elderly: Overview of systematic reviews and economic evaluations. Front Pharmacol 2019;10:302S.
26. Facchini LA, Tomasi E, Dilélio AS. Quality of primary health care in Brazil: Advances, challenges and perspectives. Saúde Debate 2018;42:208-23.
27. Firmo JO, Mambrini JV, Peixoto SV, Loyola-Filho AI, Souza PR Jr., Andrade FB, et al. Adequate control of hypertension among older adults: ELSI-Brazil. Rev Saude Publica 2018;52 Suppl 2:13S.
28. Tavares NU, Bertoldi AD, Mengue SS, Arrais PS, Luiza VL, Oliveira MA, et al. Factors associated with low adherence to medicine treatment for chronic diseases in Brazil. Rev Saude Publica 2016;50:10S.
29. Shah BM, Hajjar ER. Polypharmacy, adverse drug reactions, and geriatric syndromes. Clin Geriatr Med 2012;28:173-86.
30. Huri HZ, Wee HF. Drug related problems in Type 2 diabetes patients with hypertension: A cross-sectional retrospective study. BMC Endocr Disord 2013;13:2.
31. Yimama M, Jarso H, Desse TA. Determinants of drug-related problems among ambulatory Type 2 diabetes patients with hypertension comorbidity in Southwest Ethiopia: A prospective cross sectional study. BMC Res Notes 2018;11:679-85.
32. Nascimento YA, Carvalho WS, Acurcio FA. Drug-related problems observed in a pharmaceutical care service, Belo Horizonte, Brazil. Braz J Pharm Sci 2009;45:321-30.
33. Kovacevic SV, Miljkovic B, Culafic M, Kovacevic M, Golubovic B, Jovanovic M, et al. Evaluation of drug-related problems in older polypharmacy primary care patients. J Eval Clin Pract 2017;23:860-5.
34. Al-Azzam SI, Alzoubi KH, AbuRuz S, Alefan Q. Drug-related problems in a sample of outpatients with chronic diseases: A cross-sectional study from Jordan. Ther Clin Risk Manag 2016;12:233-9.
35. Farha RA, Basheti I, Al Ruz HA, Alsaleh A, AbuRuz S. Assessment of drug-related problems and their impact on blood pressure control in patients with hypertension. Eur J Hosp Pharm 2016;23:126-30.
36. Ministério da Saúde. In: Ministério da Saúde SDC, Tecnologia e Insumos Estratégicos, Departamento de Assistência Farmacêutica e Insumos Estratégicos, editor. Secretaria de Ciência. Resultados do Projeto de Implantação do Cuidado Farmacêutico no Município de Curitiba. Brasília: Ministério da Saúde; 2015. p. 100.
37. Conn VS, Ruppar TM, Chan KC, Dunbar-Jacob J, Pepper GA, de Geest S. Packaging interventions to increase medication adherence: Systematic review and meta-analysis. Curr Med Res Opin 2015;31:145-60.
38. Wali H, Hudani Z, Wali S, Mercer K, Grindrod K. A systematic review of interventions to improve medication information for low health literate populations. Res Social Adm Pharm 2016;12:830-64.
39. Borja-Oliveira CR. Pill organizers and pill cutters: Risks and limitations. Rev Saude Publica 2013;47:123-7.
40. Howatson A, Wall CR, Turner-Benny P. The contribution of dietitians to the primary health care workforce. J Prim Health Care 2015;7:324-32.
41. Aguiar PM, Balisa-Rocha BJ, Brito GC, da Silva WB, Machado M, Lyra DP Jr., Pharmaceutical care in hypertensive patients: A systematic literature review. Res Social Adm Pharm 2012;8:383-96.
42. Cazarim MS, de Freitas O, Penaforte TR, Achcar A, Pereira LR. Impact assessment of pharmaceutical care in the management of hypertension and coronary risk factors after discharge. PLoS One 2016;11:e0155204.
43. Obreli-Neto PR, Marusic S, Guidoni CM, Baldoni AO, Renovato RD, Pilger D, et al. Economic evaluation of a pharmaceutical care program for elderly diabetic and hypertensive patients in primary health care: A 36-month randomized controlled clinical trial. J Manag Care Spec Pharm 2015;21:66-75.
44. Kandasamy K, Natarajan A, Sebastian J, Konakalla M, Sam R, Rajagopal SS, et al. Impact of pharmacist intervention in screening and education on blood pressure in a rural area in Southern India. Asian J Pharm Clin Res 2016;9:339-43.
45. Andhuvan G, Venkatachalam VV, Sankar V. Impact of pharmacist education on medication adherance in heart failure patients. Int J Pharm Sci Res 2014;6:474-6.
46. Thomas JA, Snigdha KS, Karanath PM, Swaroop AM. Impact of patient counselling on knowledge, attitude, and practice of hypertensive patients in a tertiary care hospital. Int J Pharm Sci Res 2017;9:122-5.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.